Peroxisome proliferator activated receptor alpha inhibits hepatocarcinogenesis through mediating NF-κB signaling pathway.
about
Multiple Mechanisms of Anti-Cancer Effects Exerted by Astaxanthin.Oleoylethanolamide, an endogenous PPAR-α ligand, attenuates liver fibrosis targeting hepatic stellate cells.Identification of Haplotype Tag Single-Nucleotide Polymorphisms within the PPAR Family Genes and Their Clinical Relevance in Patients with Major TraumaTriptolide Inhibits Invasion and Tumorigenesis of Hepatocellular Carcinoma MHCC-97H Cells Through NF-κB SignalingPersistent effect of mTOR inhibition on preneoplastic foci progression and gene expression in a rat model of hepatocellular carcinoma.ChIP-on-chip analysis of thyroid hormone-regulated genes and their physiological significance.Cyclin D1 represses peroxisome proliferator-activated receptor alpha and inhibits fatty acid oxidation.PPARs and Mitochondrial Metabolism: From NAFLD to HCC.Peroxisome Proliferator-Activated Receptor Modulation during Metabolic Diseases and Cancers: Master and Minions.Pemafibrate, a novel selective peroxisome proliferator-activated receptor alpha modulator, improves the pathogenesis in a rodent model of nonalcoholic steatohepatitis.MicroRNA-33a promotes cell proliferation and inhibits apoptosis by targeting PPARα in human hepatocellular carcinoma.Communicative reprogramming non-curative hepatocellular carcinoma with low-dose metronomic chemotherapy, COX-2 inhibitor and PPAR-gamma agonist: a phase II trial.Carnitine palmitoyltransferase gene upregulation by linoleic acid induces CD4+ T cell apoptosis promoting HCC development.
P2860
Q35890732-EF4CF629-F4D8-4119-99D9-52803B227E36Q36618918-D36BE208-3689-4CF3-8EBD-9888D2A846D7Q36841634-D26F0F1F-8EBE-457C-8331-23AFFE53B708Q37036012-5E75A1F5-D771-456E-9C50-941A4E286D0DQ37220518-9BA07010-BEC3-4CAF-AF52-EE59BF07D34EQ37225571-FC9FFFA2-DCFD-4E49-860A-84B525B26FBEQ37565240-BEF99932-88C4-471B-A890-D249E1A392ACQ37575571-12FFCD0C-D2C4-4914-BB0A-FA61B7A2A0C4Q37578702-FF77EF39-2FCC-4046-86D5-5BD7D2E9F629Q37640263-4975A9A5-68F2-4F7E-B4A4-997000952C41Q38701714-02981E50-481E-4166-AB1C-505DDD78480AQ47144193-582FC711-0A66-4C14-9F1C-1C8E50422C93Q55023687-EE796986-DD74-4C89-8A56-F9AFE5DB5754
P2860
Peroxisome proliferator activated receptor alpha inhibits hepatocarcinogenesis through mediating NF-κB signaling pathway.
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Peroxisome proliferator activa ...... ating NF-κB signaling pathway.
@ast
Peroxisome proliferator activa ...... ating NF-κB signaling pathway.
@en
Peroxisome proliferator activa ...... ating NF-κB signaling pathway.
@nl
type
label
Peroxisome proliferator activa ...... ating NF-κB signaling pathway.
@ast
Peroxisome proliferator activa ...... ating NF-κB signaling pathway.
@en
Peroxisome proliferator activa ...... ating NF-κB signaling pathway.
@nl
prefLabel
Peroxisome proliferator activa ...... ating NF-κB signaling pathway.
@ast
Peroxisome proliferator activa ...... ating NF-κB signaling pathway.
@en
Peroxisome proliferator activa ...... ating NF-κB signaling pathway.
@nl
P2093
P2860
P356
P1433
P1476
Peroxisome proliferator activa ...... iating NF-κB signaling pathway
@en
P2093
Eagle S H Chu
Geoffrey Farrell
Jingwan Zhang
Minhu Chen
Narci Teoh
Ning Zhang
Xiaoxing Li
P2860
P304
P356
10.18632/ONCOTARGET.2212
P407
P577
2014-09-01T00:00:00Z